Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Non Operating Income (2016 - 2025)

Standard Biotools (LAB) has disclosed Non Operating Income for 16 consecutive years, with -$5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 663.95% to -$5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$869000.0, a 471.37% decrease, with the full-year FY2024 number at -$5.2 million, down 471.82% from a year prior.
  • Non Operating Income was -$5.4 million for Q3 2025 at Standard Biotools, down from $5.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $5.0 million in Q2 2025 to a low of -$5.4 million in Q3 2025.
  • A 5-year average of $117157.9 and a median of $315000.0 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: crashed 950.0% in 2022, then soared 2398.41% in 2023.
  • Standard Biotools' Non Operating Income stood at -$52000.0 in 2021, then plummeted by 950.0% to -$546000.0 in 2022, then skyrocketed by 301.28% to $1.1 million in 2023, then crashed by 491.9% to -$4.3 million in 2024, then fell by 25.31% to -$5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Non Operating Income are -$5.4 million (Q3 2025), $5.0 million (Q2 2025), and $3.9 million (Q1 2025).